Formulation and Evaluation of Antifungal Nanocream for Topical Drug Delivery
DOI:
https://doi.org/10.22270/ajprd.v13i6.1640Abstract
The objective of this study was to develop and optimize a nanostructured lipid carrier (NLC)-based nano cream loaded with Voriconazole for enhanced topical antifungal delivery. Voriconazole, a hydrophobic antifungal agent, exhibits poor aqueous solubility and variable bioavailability, making it a suitable candidate for lipid-based nano systems. Preformulation studies confirmed the drug's purity and solubility profile. Voriconazole was identified as a whitecrystallinepowderwithameltingpointof128–130°Canddemonstratedgoodsolubility in methanol, ethanol, and DMSO. FTIR analysis confirmed the absence of significant drug– excipient interactions.
NLCs were prepared via hot homogenization followed by ultrasonication, employing glyceryl monostearate and oleic acid as solid and liquid lipids, respectively, with Tween 80 and Poloxamer 188 as surfactants. A 3² factorial design was utilized to optimize formulations based on particle size and entrapment efficiency .Among the nine experimental batches, Batch F6 exhibited optimal characteristics,with a particle size of 182nm,PD Iof 0.22, zeta potential of –30 mV, entrapment efficiency of 89.41%, and drug loading of 31.8%.
Batch F6 was further incorporated into four nano cream formulations (F1–F4), varying in Carbopol 940 and stearic acid concentrations. Formulation F3 was identified as optimal, demonstrating excellent spreadability (6.1 gm.cm/sec), drug content (100.5%), and sustained drug release (79.5%over8hours). Anti fungal activity one of inhibition was found as 38mm. The optimized cream also maintained its physical stability, pH, and drug content under accelerated stability testing.
In conclusion, the developed Voriconazole-loaded NLC-based nano cream presents a promising and patient-compliant approach for effective topical antifungal therapy, offering improved drug delivery, stability, and therapeutic efficacy.
Downloads
References
Jaiswal P, Gidwani B and Vyas A: Nanostructured lipid carriers and their current application in targeted drug delivery. Artificial Cells Nano medicine and Biotechnology 2016; 44(1):27-40.
Sharma A and Baldi A: Nano structured lipid carriers: A review. Journal of Developing Drugs 2018; 7(2):1000191.
Nandvikar NY, Lala RR and Shinde A S: Nanostructured lipid carrier: the advanced lipid carriers. Int J Pharm Sci Res 2019; 10(12):5252-65.
Patel DK, Kesharwani R and Kumar V: Lipid nanoparticle topical and transdermal delivery: a review on production, penetration mechanism to skin. International Journal of Pharmaceutical Investigation 2019; 9(4): 148-53.
Shah R, Eldridge D, Palombo E and Harding I: Lipid nanoparticles: Production, characterization and stability. New York, NY, USA: Springer International Publ 2015.
Boskabadi M, Saeedi M, Akbari J, Morteza-Semnani K, Hashemi SM and Babaei A: Topical gel of vitamin A solid lipid nanoparticles: A hopeful promise as a dermal delivery system. Advanced Pharmaceutical Bulletin 2021; 11(4): 663.
Jenning V and Gohla S: Comparison of wax and glyceride solid lipid nanoparticles (SLN®). International Journal of Pharmaceutics 2000; 196(2): 219-22.
Mishra V, Bansal K K ,Verma A,YadavN,Thakur S, Sudhakar K and Rosenholm JM: Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics 2018; 10(4): 191.
Müller RH, Radtke M and Wissing SA: Nanostructured lipid matrices for improved microencapsulation of drugs. International J of Pharmaceutics 2002; 242(1-2): 121-8.
Jaiswal P, Gidwani B and V yas A: Nanostructured lipid carriers and their current application in targeted drug delivery. Artificial Cells Nanomedicine and Biotechnology 2016; 44(1): 27-40.
Khosa A, Reddi S and Saha RN: Nanostructured lipid carriers for site-specific drug delivery. Biomedicine & Pharmacotherapy 2018; 103: 598-613.
Soni K, Kukereja BK, Kapur M and Kohli K: Lipid nanoparticles: future of oral drug delivery and their current trends and regulatory issues. Int J Curr Pharm Rew Res2015; 7(1): 1-8.
Sharma A and Baldi A: Nanostructured lipid carriers: A review. Journal of Developing Drugs 2018; 7(2):1000191.
Joshi M and Patravale V: Formulation and evaluation of nanostructured lipid carrier (NLC)–based gel of Valdecoxib. Drug Development and Industrial Pharmacy 2006; 32(8): 911-8.
Subramaniam B, Siddik ZH and Nagoor NH: Optimization of nanostructured lipid carriers: Understanding the types, designs, and parameters in the process of formulations. Journal of Nanoparticle Research 2020; 22(6): 1-29.
Ahmad J, Rizwanullah M, Amin S, Warsi MH, Ahmad MZ and Barkat M: Nanostructured lipid carriers (NLCs): Nose-to-brain delivery and theranostic application. Current Drug Metabolism 2020; 21(14): 1136-43.
Elmowafy M and Al-Sanea M M: Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharmaceutical Journal 2021; 29(9): 999-1012.
PurohitDK:Nano-lipidcarriersfortopicalapplication:Currentscenario.AsianJournal of Pharmaceutics (AJP): Free full text articles fromAsian J Pharm 2016; 10(1).
Radtke M, Souto EB and Müller RH: Nanostructured lipid carriers:a novel generation of solid lipid drug carriers. Pharm Technol Eur 2005; 17(4): 45-50.
Fang CL, A Al-Suwayeh S and Fang JY: Nanostructured lipid carriers (NLCs)for drug delivery and targeting. Recent Patents on Nanotechnology 2013; 7(1): 41-55.
Thirupathi G, Swamy SK and Ramesh A: Solid lipid nanocarriers as alternative drug delivery system for improved oral delivery of drugs. Journal of Drug Delivery and Therapeutics 2020; 10(6): 168-72
Torchilin V: Editor Handbook of Materials for Nanomedicine: Polymeric Nanomaterials. CRC Press 2020; 16Verma, D. D., et al. (2003). Particle size of liposomes influences dermal delivery of substances. International Journal of Pharmaceutics, (258(1-2):141-151.
Lopes, L.B.(2007).Overcoming the cutaneous barrier with micro emulsions Pharmaceuticals,3(2),147–165.
Pathan, I. B., & Setty, C. M. (2009). Chemical penetration enhancers for transdermal drug delivery systems. Tropical Journal of Pharmaceutical Research, 8(2):173–179.
Barry, B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. European Journal of Pharmaceutical Sciences, 2001; 14(2):101–114.
Benson, H.A. Transdermal drug delivery: Penetration enhancement techniques .Current Drug Delivery, 2005; 2(1):23–33.
Prausnitz, M. R., & Langer, R. Transdermal drug delivery. Nature Biotechnology, 2008; 26(11):1261–1268.
Williams, A. C., & Barry, B. W. Penetration enhancers. Advanced Drug Delivery Reviews, 2004;56(5):603–618.
Zhang, L., et al.. Nanoparticles in medicine: Therapeutic applications and developments. Clinical Pharmacology & Therapeutics, 2008; 83(5), 761–769.
Souto, E. B., & Müller, R. H. Cosmetic features and applications of lipid nanoparticles (SLN®,NLC®).International Journal of Cosmetic Science,2008; 30(3),157– 165.
Prow,T.W.,etal.Nanoparticlesandmicroparticlesforskindrugdelivery. Advanced Drug Delivery Reviews 2011; 63(6):470–491.
Honeywell-Nguyen, P.L., & Bouwstra, J.A.Vesiclesin topical drug delivery: Skin penetration and barrier recovery. Advanced Drug Delivery Reviews, 2005; 57(4):411– 435.
Ventola, C. L. The nanomedicine revolution. Pharmacy and Therapeutics, 2012; 37(9):512–525.
Sahoo, S. K., et al. Nanotechnology in drug delivery. Drug Discovery Today, 2007; 12(21–2):865–873.
Nair, R., et al. Nanoparticulate drug delivery system for bioavailability enhancement of poorly water-soluble drugs. Current Nanoscience, 2010; 6(3):193–206.
Müller, R.H.,etal. Solid lipid nanoparticles (SLN) for controlled drug delivery – A review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics, 2000; 50(1):161–177.
Pardeike, J., et al. Lipid nanoparticles (SLN, NLC) in dermal drug delivery: Concepts, recent advances, and future challenges. Advanced Drug Delivery Reviews, 2009; 61(6):427–443.
Radtke, M., et al. Nanostructured lipid carriers (NLC):A novel generation of solid lipid drug carriers. Pharmaceutical Technology Europe, 2005; 17(4), 45–50.
Mehnert, W., & Mäder, K. Solid lipid nanoparticles: Production, characterization and applications. Advanced Drug Delivery Reviews, 2012; 64:83–101.
Wissing, S. A., & Müller, R. H. The influence of the crystallinity of lipid nanoparticles on the occlusive properties. International Journal of Pharmaceutics, 2003; 242(1–2):377–379.
Jenning,V.,etal.Solid lipid nanoparticles for parenteral drug delivery.Advanced Drug Delivery Reviews,2000; 47(2–3):229–245.
Müller, R. H., et al. Nanostructured lipid matrices for improved microencapsulation of drugs. International Journal of Pharmaceutics, 2002; 242(1–2):121– 128.
Beloqui, A., et al. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine: Nanotechnology, Biology and Medicine, 2016; 12(1):143–161.
Doktorovova, S., et al. Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo studies. Nanomedicine, 2014; 9(5):673–692.
Muller, R. H., et al. (2007). Nanostructured lipid carriers (NLC) in cosmetic dermal products. Advanced Drug Delivery Reviews, 2007; 59(6):522–530.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Payal Mahendra Jadhav, Dr. Ajay Randhir Fugate, Dr. Vishweshwar Mahishankar Dharashive, Vaishnavi Laxmikant Havale
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 